CAMBRIDGE, Mass., April 22, 2024 (GLOBE NEWSWIRE) -- Generation Bio Co. (GBIO) (Nasdaq:GBIO) a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases, ...
BOSTON, October 07, 2025--(BUSINESS WIRE)--nChroma Bio ("nChroma"), a genetic medicines company advancing in vivo delivery of innovative cargoes to overcome the limitations of existing therapies, ...
JERUSALEM, Aug. 16, 2023 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (ENTX), (“Entera” or the “Company”) a leader in the development of orally delivered peptides and therapeutic proteins, today announced that ...
HENDERSON, Nev.--(BUSINESS WIRE)--Zura Bio Limited (Nasdaq: ZURA) (“Zura Bio”), a multi-asset clinical-stage biotechnology company focused on developing novel medicines for immune and inflammatory ...
ST. LOUIS--(BUSINESS WIRE)--Pivot Bio, Inc., a sustainable agriculture company, solidified its leadership in the development of breakthrough crop nutrition technologies at the 2023 International ...
Contributions on the topics listed in the Conference Announcement under Section C are welcome as oral or poster presentations. All submissions, apart from invited papers, must present original work, ...
The brevity of an abstract belies its importance to a manuscript. It’s what catches a reader’s attention and helps them to decide whether a paper is relevant. Yet failing to reflect the content of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback